Huntington National Bank’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Huntington National Bank’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-4,694	Closed	-$182K	–	1850
2016 Q1	$182K	Buy	+4,694	New	+$182K	﹤0.01%	676
2015 Q2	–	Sell	-4,694	Closed	-$182K	–	1878
2015 Q1	$182K	Buy	4,694 +1,269	+37%	+$48.9K	﹤0.01%	683
2014 Q4	$115K	Buy	+3,425	New	+$121K	﹤0.01%	870

Huntington National Bank's WX Position: Q2 2016 in Review

Huntington National Bank sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q2 2016, closing a stake of 4,694 shares — an estimated $182K sold.

Huntington National Bank first reported a position in WX in Q4 2014 and held it in 3 quarters. The position peaked at $182K in Q1 2016. 0 funds tracked by Wall St. Rank hold WX as of Q2 2016.

Huntington National Bank reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q2 2016 after selling out during the quarter.
Huntington National Bank sold 4,694 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q2 2016, an estimated $182K.
Huntington National Bank first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q4 2014 and held it in 3 quarters.
Huntington National Bank's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $182K in Q1 2016.
0 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q2 2016.

Based on Huntington National Bank's 13F filing for Q2 2016, filed 25 Jul 2016.